Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation

Human Reproduction

Volumn 24, Issue 9, 2009, Pages 2238-2243

  Sánchez Serrano, María ^a,b   Novella Maestre, Edurne ^a   Roselló Sastre, Esther ^a   Camarasa, Natalia ^a   Teruel, José ^c   Pellicer, Antonio ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^c IVI Barcelona   (Spain)

Author keywords

Breast cancer; Ovarian cortex cryopreservation; Ovarian metastases

Indexed keywords

CYTOKERATIN; CYTOKERATIN CAM 5.2; GROSS CYSTIC DISEASE FLUID PROTEIN 15; MAMMAGLOBIN; TUMOR MARKER; UNCLASSIFIED DRUG; WT1 PROTEIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER PATIENT; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FERTILITY; FROZEN SECTION; GRANULOSA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; OVARY; OVARY CYST; OVARY METASTASIS; SENTINEL LYMPH NODE; THAWING;

ADULT; BIOLOGICAL MARKERS; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARRIER PROTEINS; CRYOPRESERVATION; FEMALE; GLYCOPROTEINS; HUMANS; KERATINS; LYMPHATIC METASTASIS; NEOPLASM PROTEINS; NEOPLASM STAGING; OVARY; PRIMARY OVARIAN INSUFFICIENCY; SENTINEL LYMPH NODE BIOPSY; TRANSPLANTATION, AUTOLOGOUS; UTEROGLOBIN; WT1 PROTEINS;

EID: 68949207168     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep196     Document Type: Article

References (35)

1. Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, Schmidt KL, Andersen AN, Ernst E. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 2008;23:2266-2272.
2. Blanco I, Moriyón C, Santamaría L, Carrocera A, Díaz D, Lezana M, Alvarez R, Angulo J. Our experience of the clinical application of sentinel node biopsy in breast cancer. Cir Esp 2007;82:352-357.
3. Branagan G, Hughes D, Jeffrey M, Crane-Robinson C, Perry PM. Detection of micrometastases in lymph nodes from patients with breast cancer. Br J Surg 2002;89:86-89.
4. Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R et al. Very young women (<35 years) with operable breast cancer. Features of disease at presentation. Ann Oncol 2002;13:273-279.
5. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist 2007;12:1437-1442.
6. Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF et al. Histologic localization of sentinel lymph nodes metastases in breast cancer. Am J Surg Pathol 2003;27:385-389.
7. Dolmans MM, Michaux N, Camboni A, Martinez-Madrid B, Van Langendonckt A, Nottola SA, Donnez J. Evaluation of Liberase, a purified enzyme blend, for the isolation of human primordial and primary ovarian follicles. Hum Reprod 2006;21:413-420.
8. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364: 1405-1410.
9. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003;53:342-355.
10. Gook DA, Osborn M, Archer J, Edgar DH, McBain J. Follicle development following cryopreservation of human ovarian tissue. Eur J Obstet Gynecol Reprod Biol 2004;113:60-62.
11. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer Statistics. CA Cancer J Clin 2003;53:5-26.
12. Klevesath MB, Bobrow LG, Pinder SE, Purushotham AD. The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. Br J Cancer 2005;92:2201-2205.
13. Koga T, Horio Y, Mitsudomi T, Takahashi T, Yatabe Y. Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data. J Mol Diagn 2004;6:90-95.
14. Kreunin P, Yoo C, Urquidi V, Lubman DM, Goodison S. Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model. Proteomics 2007;7:299-312.
15. Lee MS, Chang KS, Cabanillas F, Freireich EJ, Trujillo JM, Stass SA. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 1987;237:175-178.
16. Lerwill MF. Current practical applications of diagnostic immunohisto-chemistry in breast pathology. Am J Surg Pathol 2004;28:1076-1091.
17. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, Slyusarevsky E, Amariglio N, Schiff E, Rechavi G et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from haematologic cancer patients. Hum Reprod 2008;23:1007-1013.
18. Monteagudo C, Merino MJ, LaPorte N, Neumann RD. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Hum Pathol 1991;22:368-372.
19. Moritani S, Ichihara S, Hasegawa M, Endo T, Oiwa M, Yoshikawa K, Sato Y, Aoyama H, Hayashi T, Kushima R. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP15 useful in differential diagnosis? Hum Pathol 2008;39:666-671.
20. Oktay K, Buyuk E. Ovarian transplantation in humans: indications, techniques and the risk of reseeding cancer. Eur J Obstet Gynecol Reprod Biol 2004;113:S45-S47.
21. Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005;23:4347-4353.
22. Ouellette RJ, Richard D, Maicas E. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes. Am J Clin Pathol 2004;121:637-643.
23. Radford J. Autotransplantation of ovarian tissue and the risk of disease transmission. Eur J Obstet Gynecol Reprod Biol 2004;5:113-114.
24. Radford JA, Lieberman BA, Brison DR, Smith AR, Critchlow JD, Russell SA, Watson AJ, Clayton JA, Harris M, Gosden RG et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet 2001; 357:1172-1175.
25. Riccio PA, Marabini P, Seracchioli S, Mingolla GP, Pavanello PM, Andreini L, Nannini R, Severi S, Monti G, Ferrari G. The sentinel lymph node biopsy. Evolution and convalidation of the. Ann Ital Chir 2007;78:413-417.
26. Rosendahl M, Yding Andersen C, Ernst E, Westergaard LG, Rasmussen PE, Loft A, Nyboe Andersen A. Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex rpior to gonadotoxic treatment: a follow-up study. Hum Reprod 2008; 23:2475-2483.
27. Sánchez M, Alama P, Gadea B, Soares SRC, Simón C, Pellicer A. Fresh human orthotopic ovarian cortex transplantation: long-term results. Hum Reprod 2007;22:786-791.
28. Sanchez M, Novella-Maestre E, Teruel J, Ortiz E, Pellicer A. The valencia programme for fertility preservation. Clin Transl Oncol 2008;10:433-438.
29. Sasaki E, Tsunoda N, Hatanaka Y, Mori N, Iwata H, Yatabe Y. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Mod Pathol 2007;20:208-214.
30. Schröder CP, Timmer-Bosscha H, Wijchman JG, de Leij LF, Hollema H, Heineman MJ, de Vries EG. An in vitro model for purging of tumour cells from ovarian tissue. Hum Reprod 2004;19:1069-1075.
31. Seshadri T, Gook D, Lade S, Spencer A, Grigg A, Tiedemann K, McKendrick J, Mitchell P, Stern C, Seymour JF. Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer 2006;94:1007-1010.
32. Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist 2006;11:422-434.
33. TNM Classification of Malignant Tumours, 6th edn., 2002.
34. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment 16-21. Geneva: WHO, 1979.
35. Zhu W, Michael CW. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Diagn Cytopathol 2007;35:370-375.